HMGB1 attenuates anti-metastatic defence of the liver in colorectal cancer

European Journal of Cancer

Volumn 46, Issue 4, 2010, Pages 791-799

  Luo, Yi ^a   Ohmori, Hitoshi ^a   Fujii, Kiyomu ^a   Moriwaka, Yukiko ^a   Sasahira, Tomonori ^a   Kurihara, Miyako ^a   Tatsumoto, Naokuni ^b   Sasaki, Takamitsu ^c   Yamashita, Yuichi ^c   Kuniyasu, Hiroki ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b Miyoshi Central Hospital   (Japan)

^c FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Colorectal cancer; HMGB1; Kupffer cell; Liver metastasis

Indexed keywords

CD68 ANTIGEN; HIGH MOBILITY GROUP B1 PROTEIN; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; COLORECTAL CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KUPFFER CELL; LIVER METASTASIS; MALE; METASTASIS POTENTIAL; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ANIMALS; APOPTOSIS; CELL COUNT; CELL DIVISION; COLORECTAL NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HMGB1 PROTEIN; HUMANS; KUPFFER CELLS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 76049095349     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.11.011     Document Type: Article

References (31)

1. Fujimoto Y., Nakanishi Y., Sekine S., et al. CD10 expression in colorectal carcinoma correlates with liver metastasis. Dis Colon Rectum 48 (2005) 1883-1889
2. Fong Y., Kemeny N., Paty P., Blumgart L.H., and Cohen A.M. Treatment of colorectal cancer: hepatic metastasis. Semin Surg Oncol 12 (1996) 219-252
3. Cancer Statistics in Japan Editorial Board, editor. Cancer Statistics in Japan, 2005. 2001 ed. Tokyo: National Cancer Center; 2005.
4. Ohji Y., Yao T., Eguchi T., et al. Evaluation of risk of liver metastasis in colorectal adenocarcinoma based on the combination of risk factors including CD10 expression: multivariate analysis of clinicopathological and immunohistochemical factors. Oncol Rep 17 (2007) 525-530
5. Luo Y., Fujii K., Ohmori H., et al. Antisense phosphorothioate oligodeoxynucleic acid for CD10 suppresses liver metastasis of colorectal cancer. Pathobiology 76 (2009) 267-273
6. Kuniyasu H., Oue N., Sasahira T., et al. Reg IV enhances peritoneal metastasis in gastric carcinomas. Cell Prolif 42 (2009) 110-121
7. Oue N., Kuniyasu H., Noguchi T., et al. Serum concentration of Reg IV in patients with colorectal cancer: overexpression and high Reg IV serum level is associated with liver metastasis. Oncology 72 (2008) 371-380
8. Kuniyasu H., Chihara Y., and Takahashi T. Co-expression of receptor for advanced glycation end products and the ligand amphoterin associates closely with metastasis of colorectal cancer. Oncol Rep 10 (2003) 445-448
9. Kuniyasu H., Chihara Y., and Kondo H. Differential effects between amphoterin and advanced glycation end products on colon cancer cells. Int J Cancer 104 (2003) 722-727
10. Fidler I.J. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 3 (2003) 453-458
11. Kuniyasu H., Sasaki T., Sasahira T., Ohmori H., and Takahashi T. Depletion of tumor-infiltrating macrophages is associated with amphoterin expression in colon cancer. Pathobiology 71 (2004) 129-136
12. Czura C.J., Wang H., and Tracey K.J. Dual roles for HMGB1: DNA binding and cytokine. J Endotoxin Res 7 (2001) 315-321
13. Huttunen H.J., Kuja-Panula J., Sorci G., et al. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J Biol Chem 275 (2000) 40096-40105
14. Kuniyasu H., Yano S., Sasaki T., et al. Colon cancer cell-derived high mobility group 1/amphoterin induces growth inhibition and apoptosis in macrophages. Am J Pathol 166 (2005) 751-760
15. Wang H., Bloom O., Zhang M., et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285 (1999) 248-251
16. Kusume A., Sasahira T., Luo Y., et al. Suppression of dendritic cells by HMGB1 is associated with lymph node metastasis of human colon cancer. Pathobiology 76 (2009) 155-162
17. Moriwaka Y, Luo Y, Ohmori H, et al. HMGB1 attenuates anti-metastatic defense of the lymph nodes in colorectal cancer. Pathobiology, in press.
18. Kuniyasu H., Yasui W., Shinohara H., et al. Induction of angiogenesis by hyperplastic colonic mucosa adjacent to colon cancer. Am J Pathol 157 (2000) 1523-1535
19. Timmers M., Vekemans K., Vermijlen D., et al. Interactions between rat colon carcinoma cells and Kupffer cells during the onset of hepatic metastasis. Int J Cancer 112 (2004) 793-802
20. Ellerman J.E., Brown C.K., de Vera M., et al. Masquerader: high mobility group box-1 and cancer. Clin Cancer Res 13 (2007) 2836-2848
21. van der Bij G.J., Oosterling S.J., Meijer S., Beelen R.H., and van Egmond M. Therapeutic potential of Kupffer cells in prevention of liver metastases outgrowth. Immunobiology 210 (2005) 259-265
22. Khatib A.M., Auguste P., Fallavollita L., et al. Characterization of the host proinflammatory response to tumor cells during the initial stages of liver metastasis. Am J Pathol 167 (2005) 749-759
23. Martens J.H., Kzhyshkowska J., Falkowski-Hansen M., et al. Differential expression of a gene signature for scavenger/lectin receptors by endothelial cells and macrophages in human lymph node sinuses, the primary sites of regional metastasis. J Pathol 208 (2006) 574-589
24. Ichii S., Imai Y., and Irimura T. Initial steps in lymph node metastasis formation in an experimental system: possible involvement of recognition by macrophage C-type lectins. Cancer Immunol Immunother 49 (2000) 1-9
25. Leclercq I.A., Da Silva Morais A., Schroyen B., Van Hul N., and Geerts A. Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences. J Hepatol 47 (2007) 142-156
26. Sasahira T., Sasaki T., and Kuniyasu H. Interleukin-15 and transforming growth factor α are associated with depletion of tumor-associated macrophages in colon cancer. J Exp Clin Cancer Res 24 (2005) 69-74
27. Kuniyasu H., Oue N., Nakae D., et al. Interleukin-15 expression is associated with malignant potential in colon cancer cells. Pathobiology 69 (2001) 86-95
28. Kuniyasu H., Ohmori H., Sasaki T., et al. Production of interleukin 15 by human colon cancer cells is associated with induction of mucosal hyperplasia, angiogenesis, and metastasis. Clin Cancer Res 9 (2003) 4802-4810
29. Fujii K., Luo Y., Sasahira T., et al. Co-treatment with deoxycholic acid and azoxymethane accelerates the secretion of HMGB1 in IEC6 intestinal epithelial cells. Cell Prolif 42 (2009) 701-709
30. Sasaki T., Nakamura T., Rebhun R.B., et al. Modification of the primary tumor microenvironment by transforming growth factor α-epidermal growth factor receptor signaling promotes metastasis in an orthotopic colon cancer model. Am J Pathol 173 (2008) 205-216
31. In: Sobin L.H., and Wittekind C. (Eds). UICC TNM classification of malignant tumours. 6th ed. (2003), John Wiley & Sons Inc., New York